Logo image of NZM2.DE

NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:NZM2 - DK0060336014 - Common Stock

53.2 EUR
-0.36 (-0.67%)
Last: 11/27/2025, 7:00:00 PM

NZM2.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap22.05B
Revenue(TTM)5.16B
Net Income(TTM)702.70M
Shares414.56M
Float346.29M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend0.67
Dividend Yield1.63%
EPS(TTM)1.51
PE35.23
Fwd PE25.59
Earnings (Next)02-25 2026-02-25/amc
IPO1905-05-27
Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustrySpecialty Chemicals


NZM2.DE short term performance overview.The bars show the price performance of NZM2.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -2 -4 -6

NZM2.DE long term performance overview.The bars show the price performance of NZM2.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of NZM2.DE is 53.2 EUR. In the past month the price decreased by -2.85%.

NOVONESIS (NOVOZYMES) B / NZM2 Daily stock chart

NZM2.DE Competitors/Peers

The largest stocks on the EU markets in the "Specialty Chemicals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1COV.DE COVESTRO AG N/A 11.25B
SY1.DE SYMRISE AG 19.75 10.02B
AKZA.AS AKZO NOBEL N.V. 15.36 9.56B
AKU1.DE AKZO NOBEL N.V. 15.14 9.43B
SYENS.BR SYENSQO SA 21.58 7.29B
EVK.DE EVONIK INDUSTRIES AG 9.71 6.16B
AKE.PA ARKEMA 10.14 3.97B
UMI.BR UMICORE 13.47 3.75B
NVJP.DE UMICORE 12.81 3.57B
WCH.DE WACKER CHEMIE AG 153.02 3.43B
RBT.PA ROBERTET SA 18.76 1.91B
ACT.DE ALZCHEM GROUP AG 21.11 1.31B

About NZM2.DE

Company Profile

NZM2 logo image Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..

Company Info

NOVONESIS (NOVOZYMES) B

Krogshoejvej 36

Bagsvaerd DK

Employees: 10582

NZM2 Company Website

NZM2 Investor Relations

NOVONESIS (NOVOZYMES) B / NZM2.DE FAQ

What does NOVONESIS (NOVOZYMES) B do?

Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..


What is the stock price of NOVONESIS (NOVOZYMES) B today?

The current stock price of NZM2.DE is 53.2 EUR. The price decreased by -0.67% in the last trading session.


Does NZM2 stock pay dividends?

NOVONESIS (NOVOZYMES) B (NZM2.DE) has a dividend yield of 1.63%. The yearly dividend amount is currently 0.67.


What is the ChartMill technical and fundamental rating of NZM2 stock?

NZM2.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Where is NOVONESIS (NOVOZYMES) B (NZM2.DE) stock traded?

NZM2.DE stock is listed on the Frankfurt Stock Exchange exchange.


Is NOVONESIS (NOVOZYMES) B (NZM2.DE) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NZM2.DE.


What is the next earnings date for NZM2 stock?

NOVONESIS (NOVOZYMES) B (NZM2.DE) will report earnings on 2026-02-25, after the market close.


NZM2.DE Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to NZM2.DE.


Chartmill TA Rating
Chartmill Setup Rating

NZM2.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to NZM2.DE. While NZM2.DE has a great profitability rating, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NZM2.DE Financial Highlights

Over the last trailing twelve months NZM2.DE reported a non-GAAP Earnings per Share(EPS) of 1.51. The EPS decreased by -54.35% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.61%
ROA 4.31%
ROE 6.54%
Debt/Equity 0.26
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-54.35%
Revenue 1Y (TTM)59.91%

NZM2.DE Forecast & Estimates

22 analysts have analysed NZM2.DE and the average price target is 64.14 EUR. This implies a price increase of 20.56% is expected in the next year compared to the current price of 53.2.

For the next year, analysts expect an EPS growth of 44.46% and a revenue growth 5.74% for NZM2.DE


Analysts
Analysts74.55
Price Target64.14 (20.56%)
EPS Next Y44.46%
Revenue Next Year5.74%

NZM2.DE Ownership

Ownership
Inst Owners45.55%
Ins Owners0.01%
Short Float %N/A
Short RatioN/A